Advancing the Science

Mayo Clinic Medical Science Blog

Items Tagged ‘Mayo Clinic Kern Center for the Science of Health Care Delivery’

November 6th, 2017

Larger-dose opioid prescriptions not coming from emergency departments, study shows

By Adam Harringa harringaadam

Opioid prescriptions from the emergency department (ED) are written for a shorter duration and smaller dose than those written elsewhere, shows new research led by Mayo Clinic. The study, published today in the Annals of Emergency Medicine, also demonstrates that patients who receive an opioid prescription in the ED are less likely to progress to long-term use. This […]

View full entry

Tags: Dr. M Fernanda Bellolio, Dr. Molly Jeffery, Kern Center for the Science of Health Care Delivery, Mayo Clinic Kern Center for the Science of Health Care Delivery, opioid, opioid prescription


August 2nd, 2017

Mayo researchers to explore safety of combining blood-thinners

By Adam Harringa harringaadam

Millions of Americans are taking blood-thinning drugs for common medical conditions. Often, they receive prescriptions for more than one when they have multiple chronic diseases or conditions. As Americans age and the number of people on these drugs is expected to steadily increase over the coming decades, researchers are trying to better understand how the […]

View full entry

Tags: anticoagulant, antiplatelet, blood-thinner, Dr Neena Abraham, gastroenterology, Kern Center, Mayo Clinic Kern Center for the Science of Health Care Delivery, Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery


June 28th, 2017

Underused cancer test could improve treatment for thousands, Mayo Clinic study finds

By Adam Harringa harringaadam

With colon cancer, some earlier stage patients fare worse than some later stage patients, who usually benefit most from chemotherapy. But a research team at Mayo Clinic has discovered that a simple blood test could help determine which patients are at a higher risk and therefore could benefit from therapy. The researchers also found many patients who could benefit from the test likely aren’t receiving it.

View full entry

Tags: blood test, cancer, cancer staging, carcinoembryonic antigen, CEA, chemotherapy, colon cancer, Dr. Blake Spindler, Dr. David Larson, Dr. Elizabeth Habermann, Dr. Kellie Mathis, Kern Center


Contact Us · Privacy Policy